SPY422.60-0.51 -0.12%
DIA338.78-0.67 -0.20%
IXIC14,271.73+18.47 0.13%

BRIEF-Dr. Reddy's Laboratories Enters Into Voluntary Licensing Agreement With Lilly To Expand Access To Covid-19 Treatment In India

05/11/2021 15:34
BRIEF-Dr. Reddy's Laboratories Enters Into Voluntary Licensing Agreement With Lilly To Expand Access To Covid-19 Treatment In India

- Eli Lilly and Co LLY.N:

  • DR. REDDY'S LABORATORIES ENTERS INTO A VOLUNTARY LICENSING AGREEMENT WITH LILLY TO EXPAND ACCESS TO COVID-19 TREATMENT IN INDIA

  • DR.REDDY'S LABORATORIES - ENTERED AGREEMENT WITH ELI LILLY FOR MANUFACTURE AND COMMERCIALIZATION OF THE DRUG, BARICITINIB, IN INDIA

Source text for Eikon: ID:nNDL8TcSDt

Further company coverage: LLY.N


(([email protected];))